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Abstract 
Background: Blastocystis is a zoonotic protozoan parasite habit in intestinal tract of humans and wide range of 
animals. Because of the mysterious nature and unknown or less-known aspects of Blastocystis, comprehensive 
information about epidemiology of this parasite is not available. The objective of this study was to investigate 
the available parasitology studies during the last decade in Iran and determine the prevalence of Blastocystis 
and its position among other intestinal parasites. As well as, investigate the effective factors in its prevalence. 
Materials and Methods: All available studies related to the prevalence of intestinal parasites in Iran during the 
recent decade were collected using information databases. After determinant the mean prevalence of each 
parasite, the most common parasites, and effective factors on their prevalence were assessed and analyzed. 
Results: Different studies showed that the most common intestinal parasite at this period of time was 
Blastocystis spp. with 14.6% prevalence rate. Additionally, in 44.5% of cases Blastocystis spp. allocated the 
first and in 100% of cases, the first to third rank of the most common intestinal parasites in Iran. Giardia 
lamblia and Entamoeba coli were in the next category. 
Conclusion: To our knowledge, the present study is the first survey in which the Blastocystis spp. introduces as 
one of the most common intestinal parasites in human. Various factors, including the low sensitivity of routine 
diagnostic methods, hosts multiplicity, easy transportation and unknown impressive factors are effective in the 
increased prevalence of this parasite. The results of this study could improve the attitude of teachers and 
researchers towards Blastocystis spp. 
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Blastocystis is a mysterious emerging zoonotic 
protozoan parasite habit in human intestinal tract, 
many vertebrates, and even invertebrates hosts1. This 
parasite was discovered by a Russian physician, 
Fedor Aleksandrovich Lesh (Lösch), in 1870. Since 
the taxonomic status of Blastocystis was unknown at 
that time, it was ignored2. In 1912, Blastocystis was 
first described in intestinal tracts of humans and 
named Blastocystis hominis as a commensal yeast3. 
Not considering as pathogenic protozoa led to be 
forgotten for more than ten years4. In 1967, it was 
introduced as eukaryotic protozoa based on 
morphological criteria. Later, based on SSU-rRNA 
gene sequence it was placed on new rank, and apart 
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from other organisms called Stramenopiles that in 
subsequent revisions named Chromista5-7. Several 
studies introduced blastocystis as the most common 
intestinal parasite in the world8,9 that could be a 
result of low-hygiene conditions. In industrialized 
and developing countries, prevalence of this 
protozoan is about 10 and 50–60% respectively. 
Although, in the United States of America (USA) 
prevalence rate is also reported up to 23% 10-12. 
Despite it is a decade that Blastocystis spp. have been 
found, except morphological aspect (four major 
forms; cyst, granulated, amoeboid, and vacuolated 
(Fig. 1)), other biological aspects including, method 
of reproduction, life cycle, subspecies, and 
pathogenicity are not clearly specified and hence it is 
considered as a mysterious parasite13,14. 
The most important factors that led Blastocystis spp. 
to be introduced as a mysterious parasite are as 
follow; a) In addition to the binary division, as a 
usual method of reproduction (Fig. 1A), other 
method of reproduction, like plasmotomy, 
endodyogeny, schizogony, sporogony and 
germination have been reported in this protozoa. This 
variation in proliferation methods is due to the 
polymorphisms or the genetic origin of parasite13-15. 
b) Although the contaminated food/water with 
resistant cysts (in two forms of thin wall and 
causative agent of internal autoinfection; and thick 
wall with less number and causative agent of 
transmissions) have been reported as the main routes 
of transmission of the parasite16-18. Up to now, five 
different kinds of life cycle for Blastocystis spp. have 
been suggested that due to the lack of proper animal 
models, none of them is stated strictly and is 
attributable14,18. c) In addition to polymorphism, this 
protozoan has a high-heterogenesity, so that the 
SSUrRNA gene analysis indicated that genotypes, or 
subtypes (STs) of this parasite are numerous (Fig. 
2)19. Nine standard subtypes (ST1-9) of the identified 
genotypes that each tend to a specific host, and have 
been found as zoonotic in humans are the basis of 
pathogenicity of the parasites and epidemiological 
studies (Table 1). For instance, while ST5 tend to 
cows and pigs, ST2 tend to monkeys, ST6,7 in the 
mixed form to birds; and ST3 is tend more to humans 
(also called human subtypes), but none of these hosts 
is specific to the parasite and the parasite can be 
transmitted easily between them1,17,20,21. d) Many 
studies have emphasized on pathogenic potential of 
blastocystis and found numerous factors affecting its 
virulence as well. Intestinal clinical symptoms 
(giardiasis like symptoms) includes diarrhea, 
abdominal pain, weakness, weight loss, bloating and 
constipation and extra-intestinal clinical symptoms 
such as, joint pain and allergy (itching and hives) are 
attributed to Blastocystis spp. Since these protozoa 
found in patients without any clinical symptoms it 
pathogenicity is still controversial and doubtful1. 
Blastocystis spp. introduced by the World Health 
Organization of the United Nations (WHO) as one of 
the water-health indices22,23. Specific epidemiological 
conditions and pathogenicity proof of this parasite 
made a certain appeal in researchers of parasitology, 
so that most of the studies over the recent decade were 
conducted on blastocystis background as it is 
mentioned as an emerging parasite24,25.  
Objective of the preset study was to investigate the 
prevalence of intestinal parasites among studies 
conducted over the past decade in Iran and identifying 
the Blastocystis spp. position and effective factors on 
its increasing prevalence. 
Methods 
We searched all relevant information considering the 
prevalence of intestinal parasites and Blastocystis spp. 
We referred to the information databases of Medline, 
PubMed, Scopus, Google scholar, Iranmedex and SID 
and the used MESH were the combinations of 
intestinal parasites, blastocystis, prevalence and Iran. 
After calculating the mean prevalence of each parasite, 
the most common parasites, and factors affecting their 
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Results 
After investigate and analyzes the results of collected 
studies, the mean prevalence of intestinal parasites in 
Iran during the recent decade were determined (Table 
2). The most common intestinal parasites were 
Blastocystis spp., Giardia lamblia and Entamoeba 
coli with mean prevalence of 14.6, 12.45 and 7.45% 
respectively. Other intestinal parasites were in the 
next category in the rankings. Moreover, in 44.5% of 
cases Blastocystis spp. was in first rank, and in 100% 
of cases included the first to third of the most 
common intestinal parasites. 
Discussion 
Prevalence of Blastocystis spp. is differs from 
country to country, and even in different areas of a 
country. Generally, the prevalence of this parasite in 
developing countries (30–50%) is more than 
developed countries (1.5–10%), this rate related to 
several factors including, health standards, disposal of 
human waste, facing animals, and consuming the 
contaminated food and water9,26. Other risk factors 
reported for blastocystis, includes, travel to the 
tropical areas, abnormal function of the intestinal tract, 
diabetes mellitus, malignancy, immunosuppression, 
chemotherapy, and acquired immunodeficiency 
syndrome (AIDS)1,26.  
To our knowledge, the present study is the first survey 
in Iran that introduces Blastocystis spp., as one of the 
most-common intestinal parasites in Iran. It proves the 
position of the prevalence of this parasite in several 
studies that have been conducted in the past decade. In 
44.5% of studies Blastocystis spp. had the first rank 
 
Figure 1. Blastocystis spp. different morphological forms stained with various stains under microscopic examination. A; cyst-like forms 
undergoing binary fission stained with trichrome, B–E; cyst-like forms stained with trichrome, the nuclei in the peripheral cytoplasmic rim 
are visible, staining purple, F–I; spherical cyst-like stage ranging from 6-35 mm in formalin-fixed wet mount, J–M; vacuolar forms stained 
with hematoxyline, N–Q; vacuolar forms stained with iodine, R; vacuolar form in normal saline wet mount, S; granular form in normal 
saline wet mount,T; cyst-like stage in normal saline wet mount, U; amoeboid form in normal saline wet mount, V–W; vacuolar and cyst-like 
forms in normal saline wet mount, X; vacuolar form has a central vacuole with 1–4 nuclei and 5–20 microns wide on TEM, Y; cyst-like 
stage on SEM. 
Figures are reproduced from Centers for Disease Control and Prevention (CDC) at http://www.cdc.gov/dpdx/az.html. 
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and in 100% of studies allocated the rank of 1st to 3rd 
of the most common intestinal parasites27-44. This is 
in contrast to the common claim that attributes the 
position to Giardia lamblia45.The findings are 
consistent with the result of conducted studies by 
Lagace-Wiens et al. (2006) in Canada8 and Alfellani 
et al. (2013) in Taiwan9 that have reported the 
Blastocystis spp., as the most common intestinal 
parasite. Some studies have reported that one billion 
people in the world are infected with this parasite, 
and each person maybe infected to the parasite 
during the lifetime46. In addition, unlike other 
intestinal parasites, some comparative studies37, 
comparisons of different studies in Iran44,47 and even 
industrial countries like USA,12,15 have reported the 
increase in the prevalence of Blastocystis spp., which 
is apparently inconsistent with the level of education 
and health facilities of societies43. However, it is 
possible that stress or other unknown factors have a 
role in this increase46,50. 
The bovine and human subtypes reported in Iran are 
similar to other studies in the world but the Iranian 
birds have shown more resistant to parasite and had 
different subtype with other bird’s subtypes in the 
world48,49. Generally, increasing prevalence of 
Blastocystis spp. in developing countries, including 
Iran, would be due to the following reasons: 
1- Polymorphism of the parasite (Fig. 1) confuse 
experts in clinical laboratories while diagnosing, 
because of its four major forms13; the only 
detectable form is the vacuolar form, that means 
just about 25% of cases of infections are detected 
with routine diagnostic methods and many of 
infections are ignored. Parasite is capable to 
survive up to 11 months and even to the time of 
proper treatment can survive in colon50, this 
factor can be considered as a resource for the 
propagation of parasite. The only high-sensitive 
 
 
Figure 2. A phylogenetic tree comparing representative Blastocystis SSU-rDNA sequences, designated ‘BL0–’, and reference sequences 
from GenBank, shown with accession numbers. The tree is inferred, using the neighbor-joining method (with maximum composite 
likelihood model), based on a hypervariable region at the 5′ end of the SSU-rRNA gene. Proteromonas lacerate (accession number, U37108) 
is used as out group. Bootstrap values (%) are indicated at the internal nodes (1,000 replicates). Bootstrap values of <50% are not shown. 
The subtype prevalence in the 63 samples is shown to the right as a percentage19.  
This figure is reproduced directly from the study of Forsell et al., 2012 at https://researchonline.lshtm.ac.uk/149713/1/149713.pdf 
 
NBM 217    Novelty in Biomedicine 2015, 4, 214-21 
Badparva et al.                                                                  Blastocystis: Emerging Protozoan Parasite with High Prevalence in Iran  
diagnosis method that may detects all 
morphological forms of blastocystis, is the 
polymerase chain reaction (PCR)51, which due 
to high cost of equipment is not applicable in all 
laboratories.  
2- Appearance of the clinical signs is the main 
cause for referring individuals to clinics. Studies 
have shown that only some subtypes (ST1) causes 
clear symptoms in patient and consequently 
referred the person to physician52. In this case, 
most people are unaware of their infection and  
 
 
Table 1: Various geographical distribution of Blastocystis spp. subtype infecting humans58. 
No. of 
reports 
Country Type of 
Participants 
Percentage of Blastocystis sp. single subtype infection Unknown/mixed Reference 
1 2 3 4 5 6 7 8 9 
1 Bangladesh Patient 7.7 – 92.3 – – – – – – – Yoshikawa 
et al. 2004  
Germany Patient 25.0 - 41.7 – 16.7 – 16.7 – – – Yoshikawa 
et al. 2004  
Japan Patient 8.0 10.0 52.0 22.0 – – 4.0 – – 4.0 Yoshikawa 
et al. 2004  
Pakistan Patient 20.0 – 70.0 10.0 – – – – – – Yoshikawa 
et al. 2004  
2 China Patient 37.1 5.7 40.0 – – – – – – 14.3 Yan et al. 
2006  
3 China Rural 
community 
– – – – 66.7 – – – – 33.3 Yan et al. 
2007  























Patients 30.0 10.0 60.0 – – – – – – 8.0 Li et al. 
2007  
5 Denmark Patients 3.4 20.7 51.7 24.1 – – – – – – Stensvold et 
al. 2006  
6 Denmark Patients 17.9 32.1 46.6 3.8 – – – – – – Stensvold et 
al. 2007  
7 Denmark general 
population 
8.3 12.5 25 37.5 – – – – 12.5 – Stensvold et 
al. 2009  
Patient - 
Follow-up 
20.7 20.7 16.3 12.0 – – 5.4 – – 25.1 Stensvold et 
al. 2009  
8 Denmark Patients 17.4 13 33.9 13.9 – 8.7 – 8.7 – – Rene et al. 
2009  
9 Egypt Patient 18.2   54.5 – – 18.2 9.1 – – – Hussein et 
al. 2008  
10 Egypt Patient 19.1 19.1 61.8 – – – – – – 1.0 Souppart et 
al. 2010  
11 France Patient 16.7 13.3 50.0 10.0 – – 3.3 – – 6.7 Souppart et 
al. 2009  
12 Germany  Not 
available 
21.0 1.0 66.0 7.0 – – – – – 5.0 Böhm-
Gloning et 
al. 1997  
13 Greece Patient 20.0 13.3 60.0 2.2 – 2.2 2.2 – – – Menounos et 
al. 2008  
14 Greece Patient 14.0 9.8 62.7 1.9 – 1.9 9.8 – – – Vassalos et 
al. 2010  
15 Japan Patient 3.1 – 93.8 3.1 – – – – – – Yoshikawa 
et al. 2000  
16 Japan Patient 20.0 21.8 43.6 10.9 – – – – – 3.6 Kaneda et al. 
2001  
17 Malaysia Patient 45.0 5.0 50.0 – – – – – – – Tan et al. 
2008  
18 Malaysia Patient 12.5 5.0 50.0 27.5 – – – – – 2.0 Tan et al. 
2009  
19 Nepal Patient 20.0 20.0 60.0 – – – – – – – Yoshikawa 
et al. 2009  
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20 Pakistan Patient-IBS 86.0 60.0 47.0 75.0 43.0 50.0 50.0 – – 2.0 Yakoob et 
al. 2010  
Healthy 
persons 
14.0 40.0 53.0 25.0 57.0 50.0 50.0 – – – Yakoob et 
al. 2010  
21 Singapore Patient 22.0 – 78.0 – – – – – – – Wong et al. 
2008  
22 Spain Patient 2.0 3.9 – 94.1 – – – – – – Domínguez- 
Márquez et 
al. 2009  
23 Thailand Army 
personnel 
90.2 – 4.6 – – – 1.3 – – 3.9 Thathaisong 
et al. 2003  
24 Thailand School 
children 
77.9 22.1 – – – – – – – – Leelayoova 
et al. 2008  
25 Turkey Patient - 
children 
21.6 19.6 52.9 – – – – – – 5.9 Dogruman-
Al et al. 
2008  
Patient-adult 14.6 24.4 58.5 – – – – – – 2.4 Dogruman-
Al et al. 
2008  
26 Turkey Patient 9.2 13.8 75.9 – – – 1.1 – – – Ozyurt et al. 
2008  
27 Turkey Patient 2.9 28.6 60.0 – – – – – – 8.6 Dogruman-
Al et al. 
2009  
28 Turkey Patient 36.0 24.0 10.0 – – – – – – – Eroglu and 
Koltas 2010  
29 USA Patient 11.1 – 66.7 – – – – – – 22.2 Jones et al. 
2009  
 
this led to stability of the parasite, and becomes 
patients to a source of infection propagation. 
Further, despite the pathogenicity of parasite22 
many Iranian physicians still do not believe that 
and do not prescribe the proper treatment. In 
addition, the rising resistance of Blastocystis 
spp. against the only drug of choice, 
metronidazole53 will also be an important factor 
affecting its incidence. Comparison of three 
different time-interval studies using routine and 
molecular diagnostic methods in Lorestan 
province is proving for this claim12,24,25,43,47,49. 
3- Blastocystis is a heterogeneous zoonotic 
parasite with multiple subtypes (Figure 2). A 
wide range of hosts including primates, pigs, 
rodents, reptiles, amphibians, and insects have 
been reported18,54. Since, fecal-oral is the main 
route of transmission among humans and other 
hosts1,16,17, health care is important in preventing 
the infection1, and high incidence of parasite in 
developing countries may be due to the crowded 
population, poor personal and environmental 
Table 2: Frequency of gastrointestinal parasites in conducted studies in different provinces of Iran during the ten recent years and 
ranking of Blastocystis spp.  among them. 
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hygiene, lack of safe water supplies, 
socioeconomic status, and inappropriate sewage 
disposal systems. 
4- High prevalence of Blastocystis spp. in 
people who are dealing with animals55-57 or 
those who travel on weekends to recreational 
rivers15, represents the various routes of 
parasites transition. Although, as mysterious 
parasite may be transmitted in other ways as 
well. In Iran, it was found that there is a relation 
between ST5 of human strains with bovine 
source21 that would be an effective indicator for 
the increasing prevalence.  
Despite extensive studies on blastocystis throughout 
the world, Iran is still at the beginning of considering 
the pathogenicity, epidemiological aspects and 
prominence of the prevalence of this parasite. Further 
studies especially in the parasite genome in different 
hosts are recommended. It seems that disregarding 
blastocystis is unfair and helps its increasing 
prevalence. 
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